DexCom Inc (DXCM) is the lead sponsor of 1 active clinical trials listed on ClinicalTrials.gov[1].
DXCM has 1 Form 4 insider filing recorded at the SEC in the past 30 days[2].
DXCM is tracked by BiotechSigns with a current catalyst score of 34/100 and grade F. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-04.
DexCom Inc (DXCM) is the lead sponsor of 1 active clinical trials listed on ClinicalTrials.gov[1].
DXCM has 1 Form 4 insider filing recorded at the SEC in the past 30 days[2].